G6PD and G6PD deficiency: Additionally, studies by Saeed et al. (2021) also indicate that fosfomycin has a safe profile for use in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency because its metabolism does not lead to oxidation of red blood cells, which is crucial in this patient group (Saeed et al., 2021).